{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    5,
    8,
    12,
    16,
    17,
    28,
    106
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "INT-6",
        "name": "Amendment INT-6",
        "scope": {
          "id": "f6656e63-1f0d-4e47-b809-624b25e059e0",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "fa6a35be-1c6e-4ebe-bf67-e82ab1b22db7",
          "code": {
            "id": "e27def92-b60b-4e3d-a551-f8b54676bf8a",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "72885779-ccc3-49e9-837b-e0c80ecf2727",
            "type": {
              "id": "786f8c86-3bf1-4422-a81e-b2c178395835",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The primary reason for the amendment is to decrease the number of primary composite events required for the interim analysis from 540 to 405. In addition, 2 new secondary endpoints have been added and secondary endpoints have been reordered.",
        "effectiveDate": "2017-09-06",
        "reasonIds": [
          "ar_1_1",
          "ar_1_2"
        ],
        "previousVersion": "INT-5",
        "newVersion": "INT-6"
      },
      {
        "id": "amend_2",
        "number": "INT-5",
        "name": "Amendment INT-5",
        "scope": {
          "id": "3267693d-aa19-4c31-9173-cb9cbce5485c",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "7ab4198d-c23c-4263-83cd-c7acb99ffa29",
          "code": {
            "id": "c683d6f9-c023-42bc-816a-d6d81d6d242f",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "94250fe2-38e2-4700-9fce-2699bbd0f727",
            "type": {
              "id": "742764a7-6faa-456c-9d0d-16c13a57935c",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The primary reason to amend the study protocol is to include new safety information and guidance regarding subject management surrounding the event of lower extremity amputations.",
        "effectiveDate": "2016-05-06",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2"
        ],
        "previousVersion": "INT-4",
        "newVersion": "INT-5"
      },
      {
        "id": "amend_3",
        "number": "INT-4",
        "name": "Amendment INT-4",
        "scope": {
          "id": "7c51b206-c122-4860-95b3-3b824e19d638",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "77f5933e-8def-4187-b8b0-efe34c5208c9",
          "code": {
            "id": "1e89249d-5d3c-42f0-9dfa-0b8775ddf5a2",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "c595080e-796a-41f9-af24-572132f1c77a",
            "type": {
              "id": "5bec4510-b796-4631-b1da-38cd75b3166d",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "To provide further clarifications regarding ACEi or ARB therapy and modify text for clarity across multiple sections including study design and exclusion criteria.",
        "effectiveDate": "2016-01-19",
        "reasonIds": [
          "ar_3_1",
          "ar_3_2"
        ],
        "previousVersion": "INT-3",
        "newVersion": "INT-4"
      },
      {
        "id": "amend_4",
        "number": "INT-3",
        "name": "Amendment INT-3",
        "scope": {
          "id": "01ed5a23-9a10-4dfe-92b7-28d4084c8b7a",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "48862377-e0be-46e1-bab2-eb6821c67d40",
          "code": {
            "id": "cc41ff5a-a72c-4f51-9bb7-654ccedfb593",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "336cec70-4fa0-4ec9-a86c-0dc5abc89406",
            "type": {
              "id": "c67c2f6f-ecc7-4293-a4e9-0fda8f7ab727",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The summary for this amendment was not explicitly detailed in the provided text, but involved modifications to study design and exclusion criteria.",
        "effectiveDate": "2015-09-29",
        "reasonIds": [
          "ar_4_1"
        ],
        "previousVersion": "INT-2",
        "newVersion": "INT-3"
      },
      {
        "id": "amend_5",
        "number": "INT-2",
        "name": "Amendment INT-2",
        "scope": {
          "id": "c86f1be9-c1bf-4aff-af28-6c51933211b3",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "a380ab82-04b3-4687-88c5-cf29a8c1a993",
          "code": {
            "id": "aa7110af-950a-41c3-a9b9-9c7ba76cf8f1",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "0eabba6f-39d4-4f0b-9366-db35256683ad",
            "type": {
              "id": "cf8b9138-3281-41fb-8b13-66a49ca61f8e",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "To revise inclusion criteria to allow patients with higher baseline HbA1c values who may benefit from the study treatment to participate in the study. In addition, changes to the prescreening assessment are intended to allow a wider range of measures to prescreen subjects for albuminuria/proteinuria.",
        "effectiveDate": "2015-02-03",
        "reasonIds": [
          "ar_5_1",
          "ar_5_2"
        ],
        "previousVersion": "INT-1",
        "newVersion": "INT-2"
      },
      {
        "id": "amend_6",
        "number": "INT-1",
        "name": "Amendment INT-1",
        "scope": {
          "id": "30b9b80f-b720-4588-b2a1-ec76ad2d3cba",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "0fa4523f-97a3-4b5c-a267-1fcf04cc8cd0",
          "code": {
            "id": "21b5d61c-c3ed-490b-b51f-ae62b1489a22",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "b9af51e7-a7a8-49bd-8e1e-df8f07c6c01f",
            "type": {
              "id": "c3755ac3-7bec-4305-ae93-ca75ebdb5732",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The primary reason for the amendment to the protocol is to reflect recommendations from the United States (US) Food and Drug Administration (FDA) for study 28431754DNE3001.",
        "effectiveDate": "2014-06-12",
        "reasonIds": [
          "ar_6_1",
          "ar_6_2"
        ],
        "previousVersion": "Original Protocol",
        "newVersion": "INT-1"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_1_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "SAFETY",
        "description": "Safety",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_3_1",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_3_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_4_1",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_5_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_5_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_6_1",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_6_2",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "United States",
        "instanceType": "Country",
        "code": "US"
      }
    ],
    "studySites": [],
    "summary": {
      "amendmentCount": 6,
      "countryCount": 1,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Global",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1"
      ],
      "regions": [
        "North America",
        "Europe"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "INT-6",
        "effectiveDate": "2017-09-06",
        "summary": "The primary reason for the amendment is to decrease the number of primary composite events required for the interim analysis from 540 to 405. In addition, 2 new secondary endpoints have been added and secondary endpoints have been reordered.",
        "previousVersion": "INT-5",
        "newVersion": "INT-6",
        "reasons": [
          "Scientific",
          "Operational"
        ]
      },
      {
        "number": "INT-5",
        "effectiveDate": "2016-05-06",
        "summary": "The primary reason to amend the study protocol is to include new safety information and guidance regarding subject management surrounding the event of lower extremity amputations.",
        "previousVersion": "INT-4",
        "newVersion": "INT-5",
        "reasons": [
          "Safety",
          "Regulatory"
        ]
      },
      {
        "number": "INT-4",
        "effectiveDate": "2016-01-19",
        "summary": "To provide further clarifications regarding ACEi or ARB therapy and modify text for clarity across multiple sections including study design and exclusion criteria.",
        "previousVersion": "INT-3",
        "newVersion": "INT-4",
        "reasons": [
          "Administrative",
          "Operational"
        ]
      },
      {
        "number": "INT-3",
        "effectiveDate": "2015-09-29",
        "summary": "The summary for this amendment was not explicitly detailed in the provided text, but involved modifications to study design and exclusion criteria.",
        "previousVersion": "INT-2",
        "newVersion": "INT-3",
        "reasons": [
          "Operational"
        ]
      },
      {
        "number": "INT-2",
        "effectiveDate": "2015-02-03",
        "summary": "To revise inclusion criteria to allow patients with higher baseline HbA1c values who may benefit from the study treatment to participate in the study. In addition, changes to the prescreening assessment are intended to allow a wider range of measures to prescreen subjects for albuminuria/proteinuria.",
        "previousVersion": "INT-1",
        "newVersion": "INT-2",
        "reasons": [
          "Scientific",
          "Operational"
        ]
      },
      {
        "number": "INT-1",
        "effectiveDate": "2014-06-12",
        "summary": "The primary reason for the amendment to the protocol is to reflect recommendations from the United States (US) Food and Drug Administration (FDA) for study 28431754DNE3001.",
        "previousVersion": "Original Protocol",
        "newVersion": "INT-1",
        "reasons": [
          "Regulatory",
          "Scientific"
        ]
      }
    ],
    "geographicScope": {
      "type": "Global",
      "countries": [
        {
          "name": "United States",
          "code": "US"
        }
      ],
      "regions": [
        "North America",
        "Europe"
      ],
      "plannedSites": null
    },
    "sites": []
  }
}